Insights

Loading spinner
Gathering insights about Pulmonx Corporation

Similar companies to Pulmonx Corporation

Pulmonx Corporation Tech Stack

Pulmonx Corporation uses 8 technology products and services including Microsoft Advertising, Moat, Shopify, and more. Explore Pulmonx Corporation's tech stack below.

  • Microsoft Advertising
    Advertising
  • Moat
    Analytics
  • Shopify
    E-commerce
  • Underscore.js
    Javascript Libraries
  • Slider Revolution
    Miscellaneous
  • Priority Hints
    Performance
  • FedEx
    Transportation And Fleet Management
  • Google Analytics
    Web Analytics

Media & News

Pulmonx Corporation's Email Address Formats

Pulmonx Corporation uses at least 1 format(s):
Pulmonx Corporation Email FormatsExamplePercentage
FLast@pulmonx.comJDoe@pulmonx.com
98%
Last@pulmonx.comDoe@pulmonx.com
1%
FMiddleLast@pulmonx.comJMichaelDoe@pulmonx.com
1%

Frequently Asked Questions

Where is Pulmonx Corporation's headquarters located?

Minus sign iconPlus sign icon
Pulmonx Corporation's main headquarters is located at 700 Chesapeake Drive,, Redwood City, CA 94063, US. The company has employees across 5 continents, including North AmericaEuropeOceania.

What is Pulmonx Corporation's phone number?

Minus sign iconPlus sign icon
You can contact Pulmonx Corporation's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Pulmonx Corporation's official website and social media links?

Minus sign iconPlus sign icon
Pulmonx Corporation's official website is pulmonx.com and has social profiles on LinkedInCrunchbase.

How much revenue does Pulmonx Corporation generate?

Minus sign iconPlus sign icon
As of July 2025, Pulmonx Corporation's annual revenue reached $75M.

What is Pulmonx Corporation's SIC code NAICS code?

Minus sign iconPlus sign icon
Pulmonx Corporation's SIC code is 3841 - Surgical and Medical Instruments and Apparatus NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Pulmonx Corporation have currently?

Minus sign iconPlus sign icon
As of July 2025, Pulmonx Corporation has approximately 286 employees across 5 continents, including North AmericaEuropeOceania. Key team members include Vice President Of Commercial Operations: B. H.Vice President Of Clinical Affairs: R. M.Vice President Ra And Qa: M. F.. Explore Pulmonx Corporation's employee directory with LeadIQ.

What industry does Pulmonx Corporation belong to?

Minus sign iconPlus sign icon
Pulmonx Corporation operates in the Medical Equipment Manufacturing industry.

What technology does Pulmonx Corporation use?

Minus sign iconPlus sign icon
Pulmonx Corporation's tech stack includes Microsoft AdvertisingMoatShopifyUnderscore.jsSlider RevolutionPriority HintsFedExGoogle Analytics.

What is Pulmonx Corporation's email format?

Minus sign iconPlus sign icon
Pulmonx Corporation's email format typically follows the pattern of . Find more Pulmonx Corporation email formats with LeadIQ.

How much funding has Pulmonx Corporation raised to date?

Minus sign iconPlus sign icon
As of July 2025, Pulmonx Corporation has raised $338M in funding. The last funding round occurred on Oct 01, 2020 for $190M.
Pulmonx Corporation

Pulmonx Corporation

Medical Equipment ManufacturingUnited States201-500 Employees

Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1 

Complications of the Zephyr Endobronchial Valve treatment can include but are not limited to pneumothorax, worsening of COPD symptoms, hemoptysis, pneumonia, dyspnea and, in rare cases, death.1

1. Criner G et al AM J Resp Crit Care Med 2018, Published on 22-May-2018 as 10.1164/rccm.201803-0590OC

Brief Statement: The Pulmonx Zephyr® Endobronchial Valves are implantable bronchial valves indicated for the bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. The Zephyr Valve is contraindicated for: Patients for whom bronchoscopic procedures are contraindicated; those with evidence of active pulmonary infection; known allergies to Nitinol (nickel-titanium) or its constituent metals (nickel or titanium); known allergies to silicone, or with large bullae encompassing greater than 30% of either lung; Patients who have not quit smoking. The Zephyr Valve should be used with caution and only after careful consideration in treating patients with: Prior lung transplant, LVRS, median sternotomy, or lobectomy; Congestive heart failure or recent myocardial infarction; FEV1 <15% of predicted value. Use is restricted to a trained physician. Prior to use, please reference the Zephyr Endobronchial Valve System Instructions for more information on indications, contraindications, warnings, all precautions, and adverse events.

Section iconCompany Overview

Headquarters
700 Chesapeake Drive,, Redwood City, CA 94063, US
Phone number
SIC Code
3841 - Surgical and Medical Instruments and Apparatus
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
201-500

Section iconFunding & Financials

  • $338M

    Pulmonx Corporation has raised a total of $338M of funding over 4 rounds. Their latest funding round was raised on Oct 01, 2020 in the amount of $190Mas a IPO.

  • $50M$100M

    Pulmonx Corporation's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $338M

    Pulmonx Corporation has raised a total of $338M of funding over 4 rounds. Their latest funding round was raised on Oct 01, 2020 in the amount of $190Mas a IPO.

  • $50M$100M

    Pulmonx Corporation's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.